Leon Hooftman

Leon Hooftman, M.D., Chief Medical Officer. He is an accomplished pharmaceutical physician with more than 20 years of experience in pharmaceutical drug development in the areas of immunology, haematology, and oncology, and has several New Drug Applications to his credit. Before joining Polyphor Dr. Hooftman was CMO of Synthon BV. Previously he was CMO at Chroma Therapeutics Ltd, where he moved after having been Head of Clinical Development at Celltech. Prior to that, he was Clinical Science Director Oncology and Immunology in global drug development at Roche for several years. Dr. Hooftman holds an M.D. and B.Sc. in medical sciences of Utrecht University and is a registered medical practitioner in the UK and the Netherlands.